Bone seeking radiopharmaceuticals

International Journal of Radiation Applications and Instrumentation.

Volumn 17, Issue 2, 1990, Pages 161-179

  De Ligny, C L ^a   Gelsema, W J ^a   Tji, T G ^a   Huigen, Y M ^a   Vink, H A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; DIAGNOSTIC AGENT; PLASMA PROTEIN; TECHNETIUM COMPLEX; ETIDRONIC ACID TECHNETIUM NITRIDE TC 99M; RADIOISOTOPE; UNCLASSIFIED DRUG;

BONE; CHEMISTRY; HUMAN; METABOLISM; PROTEIN BINDING; REVIEW; SCINTISCANNING; BONE SCINTISCANNING; METHODOLOGY; PRIORITY JOURNAL;

BLOOD PROTEINS; BONE AND BONES; CHEMISTRY; DIPHOSPHONATES; HUMAN; ORGANOTECHNETIUM COMPOUNDS; PROTEIN BINDING;

EID: 0025038245     PISSN: 08832897     EISSN: None     Source Type: Journal    
DOI: 10.1016/0883-2897(90)90144-P     Document Type: Review

References (107)

1. Radiobiologic implications of the microscopic distribution of energy from radionuclides
2. Tin-119m Moessbauer spectroscopy and phosphorus-31 and tin-119 NMR of mixed aqueous 1-hydroxyethylidene-1 1-disodium phosphonate (EHDP) and tin(II) chloride solutions evidence for EHDP-tin complexes
3. 99Te d'une solution aqueuse mixte d'EHDP, d'étain et de technetium
4. 199 for radioimmunotherapy
5. Surface poisoning of synthetic and biological apatites
6. Sites and mechanisms of localization of technetium-99m phosphorus radiopharmaceuticals in acute myocardial infarcts and other tissues
7. Tc-99m oxidation state measurement by internal conversion electron spectroscopy (ICES)
8. Skeletal blood flow implications for bone scan interpretation
9. 153Sm-EDTMP on calcium hydroxyapatite
10. A comparison of phosphate bone-scanning agents in normal subjects and patients with malignant disease
11. Technetium and tin diphosphonates
12. The oxidation of Sn(II) diphosphonates by pertechnetate followed with differential pulse polarography and Mössbauer spectroscopy
13. The chemistry of technetium(V)
14. Molecular weights of technetium hydroxyethylidene diphosphonate complexes
15. Preparation and biological distribution of technetium diphosphonate radiotracers synthesized without stannous ion
16. Technetium chemistry and technetium radiopharmaceuticals
17. The chemistry of rhenium and technetium as related to the use of isotopes of these elements in therapeutic and diagnostic nuclear medicine
18. Chemical aspects of fast atom bombardment
19. 99mTc valent form in solids by measurement of internal conversion electrons
20. 99mTc in technetium chelates studied by the ICES method
21. 99mTc chemical state using the internalconversion-electron spectroscopy (ICES) method
22. Skeletal uptake of diphosphonate a review
23. 99mTc diphosphonate bone-scanning agents
24. 99mTc-pyrophosphate in the detection of bone metastases
25. 99mTc-MDP in the detection of bone metastases: concise communication
26. An analysis of factors which influence the local accumulation of bone-seeking radiopharmaceuticals
27. 153Sm radiotherapeutic bone agents
28. Skeletal localization of samarium-153 chelates potential therapeutic bone agents
29. 99mTc labelled osteotropic radiopharmaceuticals
30. 99mTc(Sn)EHDP complexes by HPLC and GPC
31. 99mTc(Sn)EHDP
32. 113Sn)-MDP to human serum albumin. The influence of various technetium, tin, and MDP concentrations
33. 99Tc
34. 99mTc in complexes with MDP and DTPA
35. Electrochemistry of technetium radiopharmaceuticals: coulometric reduction of pertechnetate in the presence of HEDP
36. Adsorption of human serum albumin on precipitated hydroxylapatite
37. Fluid space in bone
38. 99mTc(Sn)-EHDP: the influence of pH and EHDP-concentration on the size of its constituents
39. 99mTc(Sn)-MDP complexes: influence of eluent composition, determination of void volume and charge of the main component
40. 99mTc-diphosphonate complexes
41. 99mTc(Sn)-MDP constituents at neutral pH
42. 99mTc(Sn)-MDP complexes to human serum albumin and other blood proteins determined with gel chromatography and ultrafiltration
43. 99mTc(Sn)-diphosphonate complexes on tricalciumphosphate: the influence of preparation conditions, incubation media, adsorption conditions and ligand-type. The reversibility of the adsorption
44. Extraction of Tc(V) from radiopharmaceuticals
45. The chemistry of technetium I II III and IV
46. 99mTc-labeled compounds prepared with chrome (II) as reducing agent
47. Studies on bone ion exchanges using multiple-tracer indicator-dilution techniques
48. 186Re-HEDP as bone therapeutic radiopharmaceuticals
49. The valence state of technetium-99 in its complexes with bleomycin 1-hydroxy-ethylidene-1 1-diphosphonate and human serum albumin
50. Pharmaco-kinetics of current skeletal-seeking radiopharmaceuticals
51. 99mTc bone scanning agents. Preparation and chemical analysis of Tc(Sn)pyrophosphate, Tc(Sn)-MDP and Tc(Sn)HMDP
52. 99mTc(Sn)-pyrophosphate complexes
53. 99mTc(Sn)HMDP
54. 99mTc skeletal imaging agents
55. On the influence of pH and salt composition on the partition of polyelectrolytes in aqueous polymer two-phase systems
56. The influence of the salt composition of the eluent on the distribution coefficient of bovine serum albumin in gel permeation chromatography at low pH
57. Influence of salt composition ionic strength and pH of eluent on the distribution coefficient of ribonuclease in gel permeation chromatography
58. Research reactor production of radioisotopes for medical use
59. Preparation of rhenium-186 labelled EHDP and its possible use in the treatment of osseous neoplasms
60. Separation and characterization of technetium hydroxyethylidene diphosphonate and technetium formate complexes
61. Liquid chromatography of tin-reduced technetium hydroxyethylidene diphosphonate complexes for on-line spectral characterization and double isotope labeling
62. Raman spectroscopic evidence for Tc-oxo cores in Tc-HEDP complexes
63. Valence state of technetium in technetium methylene diphosphonate at tracer concentrations measured by amperometry
64. Verbindungen des Technetiums (IV) mit Hydroxyäthylidendiphosphonsäure
65. 2) methylene diphosphonate complexes
66. The bone:blood equilibrium: a possible system for its study in vitro
67. 99mTc(Sn)EHDP complexes, and the influence of the Sn(II) concentration on the composition of the reaction mixture
68. Albumin in bone
69. 4 on the solubility, dissolution and growth of bone mineral
70. 99mTc-DPD and Tc-HDP for the detection of bone metastases
71. The electrochemical reduction of pertechnetate in aqueous hydroxyethylidene diphosphonate media
72. Bioinorganic activity of technetium radiopharmaceuticals
73. 99mTc-diphosphonates in osteogenic tissue
74. Treatment of metastatic bone pain with strontium-89
75. A crossover study comparing Tc-99m-HMDP and MDP in patients
76. Recent developments in the analytical chemistry of rhenium and technetium
77. Mean ionic charge on two components of technetium pyrophosphate prepared using stannous chloride
78. Oxidation state of technetium in bone scanning agents as determined at carrier concentration by amperometric titration
79. 99mTc]MDP: chromatographic pattern, stability and biodistribution in rats
80. 99mTc-MDP
81. 99mtechnetium in bone
82. Some fundamental aspects of technetium chemistry
83. 99mTc-polyphosphate and Tc-diphosphonate
84. Exclusion chromatography of inorganic compounds
85. Reduction of pertechnetate-99m ion by hydrochloric acid I Preparation of chromatographically pure technetium-99m(IV)
86. 99mTc-Sn-hydroxymethylene diphosphonate
87. 18F, and skeletal radiography. A comparison of sensitivity
88. Clinical comparison of technetium-99m diphosphonate and pyrophosphate in bone scintigraphy concise communication
89. The reduction of pertechnetate-99 by stannous chloride—II The stoichiometry of the reaction in aqueous solutions of several phosphorus(V) compounds
90. New diphosphonate compounds for skeletal imaging comparison with methylene diphosphonate
91. Calcitonin, phosphate and the osteocyte-osteoblast bone cell unit
92. 4)-MDP radiopharmaceutical analogues
93. The biological distributions of some technetium MDP components isolated by anion exchange high performance liquid chromatography
94. X-ray photoelectron spectroscopy of potential technetium-based organ imaging agents
95. 99mTc(Sn)MDP complexes. Characterization of Tc(III)—, Tc(IV)— and Tc(V)-EHDP complexes
96. Etude de quelques propriétés physicochimiques et analytiques de rhénium
97. Chemical and physical properties of radionuclides
98. Comparison of desorption ionization methods for the analysis of neutral seven-coordinate technetium radiopharmaceuticals
99. 113Sn
100. 99mTc(Sn)EHDP on its tissue distribution in the rat
101. The presence of lining cells on surfaces of human trabecular bone
102. Relative lesion detection ability of Tc-99m HMDP and Tc-99m MDP concise communication
103. 99mTc-labelled compounds prepared with molybdenum III as reducing agent
104. 99mTc-labelled compounds prepared with tungsten (III) as the reducing agent
105. 186Re-HEDP: a potential therapeutic bone agent
106. Determination of charge and size of technetium diphosphonate complexes by anion-exchange liquid chromatography
107. 4)-HEDP components separated by anion exchange HPLC